- ￥172 - 1584
- TargetMol
- T8416
- 2026年07月07日
2 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号：
1029714-89-3
- 规格：
1mg/5mg/10mg/25mg/50mg/100mg
| 规格： | 1mg | 产品价格： | ￥172.0 |
|---|---|---|---|
| 规格： | 5mg | 产品价格： | ￥364.0 |
| 规格： | 10mg | 产品价格： | ￥509.0 |
| 规格： | 25mg | 产品价格： | ￥794.0 |
| 规格： | 50mg | 产品价格： | ￥1112.0 |
| 规格： | 100mg | 产品价格： | ￥1584.0 |
Product Introduction
Bioactivity
| 名称 | Capmatinib xHCl |
| 描述 | Capmatinib xHCl (INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor, potently blocking in vitro kinase activity (IC50 = 0.13 nM) as well as constitutive or HGF-stimulated activity in cells (IC50 values range from 0.3 to 1.1 nM). |
| 体外活性 | Capmatinib hydrochloride 在多种癌症细胞中阻断细胞增殖和迁移或诱导凋亡。[1] |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 4.49 mg/mL (10 mM), Sonication is recommended. |
| 关键字 | U-87MG | SNU-5 | S114 | orally active | Inhibitor | inhibit | INCB-28060 | INCB 28060 | INC-280 | INC 280 | HGFR | H441 | c-Met/HGFR | cMet/HGFR | c-Met | cMet | Capmatinib xHCl | Capmatinib | Balb/c nu/nu mice | ATP competitive | Apoptosis |
| 相关产品 | Formamide | Urea | Sodium Molybdate | Dimethyl phthalate | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Metronidazole | Sildenafil citrate | Citric Acid Triammonium | Stavudine | Tamoxifen |
| 相关库 | Bioactive Compound Library | Anti-Cancer Active Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Approved Drug Library | FDA-Approved Drug Library | Membrane Protein-targeted Compound Library | FDA-Approved Kinase Inhibitor Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
官网有文献
技术资料暂无技术资料 索取技术资料
文献支持
化合物 Capmatinib xHCl【1029714-89-3】
￥172 - 1584
